Interleukin-2 fusion protein: An investigational therapy for interleukin-2 receptor expressing malignancies
Open Access
- 31 January 1997
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33, S34-S36
- https://doi.org/10.1016/s0959-8049(96)00327-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the working formulation of non-Hodgkin's lymphomas for clinical usageCancer, 1994
- Cloning of the γ Chain of the Human IL-2 ReceptorScience, 1992
- Cutaneous lymphomas other than mycosis fungoides: follow-up study of 52 patients.Journal of Clinical Oncology, 1991
- Impact of interleukin‐2‐receptor‐targeted cytotoxins on a unique model of murine interleukin‐2‐receptor‐expressing malignancyInternational Journal of Cancer, 1991
- The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative ActivitiesScience, 1987
- Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphomaBlood, 1987
- The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant LymphocytesScience, 1986
- Intracellular pathway of interleukin 2 following receptor‐mediated endocytosisEuropean Journal of Immunology, 1986
- Expression of interleukin 2 receptors on activated human B cells.The Journal of Experimental Medicine, 1984
- Prospective Staging Evaluation of Patients with Cutaneous T-Cell LymphomasAnnals of Internal Medicine, 1980